跳至主要内容
临床试验/NCT05672160
NCT05672160已完成不适用

CT Evaluated Sarcopenia Independently Predicts the Overal Survival After Transcatheter Aortic Valve Implantation

Nemocnice AGEL Trinec-Podlesi a.s.1 个研究点 分布在 1 个国家目标入组 930 人开始时间: 2022年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
930
试验地点
1
主要终点
Overal survival

研究概览

简要总结

The goal of this observational study is to compare the overal survival after transcatheter aortic valve implantation (TAVI) according to sarcopenia status evaluated from preprocedural CT scans.

The main question it aims to answer is:

• Is CT evaluated sarcopenia an independent predictor of overal survival after TAVI?

详细描述

The patients suffering from aortic valve stenosis, that are not eligible for cardiosurgery were indicated to miniinvasive transcatheter aortic valve implantation (TAVI). The follow up of 930 patients were done in time interval from 1 to 11 years. In every patient the preprocedural CT scans were done. From these CT scans the L3 cross sections will be used for sarcopenia evaluation. Then we will statisticaly evaluate the overal survival after TAVI procedure in the relation with sarcopenia status. We will answer the main question: Is CT evaluated sarcopenia an independent predictor of overal survival after TAVI?

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

性别
All
接受健康志愿者

入选标准

  • patients udergone TAVI procedure

排除标准

  • patients with incomplete TAVI procedure, patients without clinical follow up

结局指标

主要结局

Overal survival

时间窗: 11 years

Time from the TAVI procedure to death

次要结局

未报告次要终点

研究者

发起方
Nemocnice AGEL Trinec-Podlesi a.s.
申办方类型
Other
责任方
Principal Investigator
主要研究者

Matej Pekar, MD, PhD

Mr. Matej Pekar, MD, PhD

Nemocnice AGEL Trinec-Podlesi a.s.

研究点 (1)

Loading locations...

相似试验